MY119359A - Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis. - Google Patents

Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.

Info

Publication number
MY119359A
MY119359A MYPI9302249A MY119359A MY 119359 A MY119359 A MY 119359A MY PI9302249 A MYPI9302249 A MY PI9302249A MY 119359 A MY119359 A MY 119359A
Authority
MY
Malaysia
Prior art keywords
interferon
side effects
reducing
treatment
viral hepatitis
Prior art date
Application number
Inventor
Lawrence M Blatt
Milton W Taylor
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Priority to MYPI9302249 priority Critical patent/MY119359A/en
Publication of MY119359A publication Critical patent/MY119359A/en

Links

Abstract

METHODS FOR THE TREATMENT OF CELL PROLIFERATION DISORDERS,VIRAL INFECTIONS, AND OTHER CONDITIONS WITHOUT CAUSING SIGNIFICANT SIDE EFFECTS NORMALLY ASSOCIATED WITH INTERFERON THEREPY, INVOLVING ADMINISTERING TO A PATIENT IN NEED THEREOF A THERAPEUTICALLY EFFECTIVE AMOUNT OF CONSENSUS HUMAN LEUKOCYTE INTERFERON ARE DISCLOSED. ALSO DISCLOSED ARE PHARMACEUTICAL COMPOSITIONS OF CONSENSUS HUMAN LEUKOCYTE INTERFERON.(FIG. 1)
MYPI9302249 1993-10-27 1993-10-27 Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis. MY119359A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI9302249 MY119359A (en) 1993-10-27 1993-10-27 Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI9302249 MY119359A (en) 1993-10-27 1993-10-27 Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.

Publications (1)

Publication Number Publication Date
MY119359A true MY119359A (en) 2005-05-31

Family

ID=47264379

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI9302249 MY119359A (en) 1993-10-27 1993-10-27 Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.

Country Status (1)

Country Link
MY (1) MY119359A (en)

Similar Documents

Publication Publication Date Title
HK1018595A1 (en) Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis
IL134345A0 (en) Methods for treatment of patients afflicted with multiple sclerosis using consensus interferon
HK1084862A1 (en) Use of omega interferon in the manufacturing of a medicament for treating viral disease in a warm-blooded animal subject
AU1854695A (en) The use of interferon subtypes in the preparation of medicaments to treat viral infections
EP0625991A4 (en) Improved alpha interferon composition and method for its production from human peripheral blood leukocytes.
MY117781A (en) Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
DE69130063T2 (en) ANTIVIRAL MEDICINAL PRODUCT PROSTRATIN
SG52537A1 (en) Methods and compositions for the treatment of cell proliferation disorders
MY105798A (en) Treatment of leukocyte dysfunction with gm-csf.
DK0862454T3 (en) CTLA-8 in combination with G-CSF or with G-CSF and IL-6 and use of CTLA-8 to treat infections
MY119359A (en) Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.
NZ514629A (en) PEGylated interferon-alpha administered at about 4.5- 9.0 micrograms/kg/week as a renal cell carcinoma treatment
MY111746A (en) Therapeutic nucleosides.
GEP19991514B (en) Method for Treatment with Interferon
MX9307639A (en) METHOD FOR TREATING VIRAL INFECTIONS WITH CONJUNCTIVE THERAPY WITH COMPOUNDS SIMILAR TO ACICLOVIR AND AN ANALOGUE OF 2'-VIRIL SUBSTITUTED NUCLEOSIDE.
IT1284852B1 (en) Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases
IT1283945B1 (en) Use of natural human alpha-interferon - in preparation of liquid medicaments for peroral administration for treating viral infections, neoplasia and immune diseases
HUP9902188A2 (en) Pharmaceutical compositions comprising natural human alfa-interferon
MY111342A (en) Method and composition for treatment of patients having decompensated liver disease